Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useMain Properties of the THERAFLEX MB-Plasma System for Pathogen ReductionFactor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System.
P2860
Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@en
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@nl
type
label
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@en
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@nl
prefLabel
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@en
Quality and safety of fresh-fr ...... x filter: 5 years' experience.
@nl
P2093
P2860
P1433
P1476
Quality and safety of fresh-fr ...... ex filter: 5 years' experience
@en
P2093
Anagnostopoulos N
Gorgolidis G
Hantziara S
Kavallierou L
Triantaphylou V
Tsoutsos D
Ziroyannis P
P2860
P304
P356
10.1111/J.1423-0410.2007.00898.X
P577
2007-05-01T00:00:00Z